Category: Clinical Breakthroughs
-
Fellow Quantifies Healthy Years Gained by Avoiding Heart Failure Risk Factors
The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
-
Living After Cancer
Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
-
Investigating Coronary Artery Calcification in Low-Risk Women
Coronary artery calcium — a sign of atherosclerosis — was found in more than one-third of women previously considered to be low-risk for heart disease, according to a Northwestern Medicine study.
-
Unlocking the Secrets to ‘SuperAging’
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
-
Hope For Fertility — in the Face of Cancer
Through pioneering research in oncofertility, reproductive endocrinologist Teresa Woodruff, PhD, offers young cancer survivors options to have children.
-
Medical Student Investigates Opioid Prescription Practices in Sickle Cell Disease
Standard guidelines are needed for prescribing opioids to children discharged after a sickle cell disease pain episode, according to a recent Northwestern Medicine study.
-
Scientists Develop Soft, Microfluidic ‘Lab on the Skin’ for Sweat Analysis
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
-
Investigating Clinical Trends in HIV-Associated Cancers
Two HIV-associated cancers are less common since the advent of antiretroviral therapy, but still occur in patients with controlled HIV, according to a Northwestern Medicine study.
-
Short Episodes of Atrial Fibrillation Don’t Increase Stroke Risk
Patients with pacemakers or defibrillators who experience only short episodes of atrial fibrillation are not at an increased risk for stroke, according to a Northwestern Medicine study.
-
New Drug Clears Atopic Dermatitis in Clinical Trials
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.
